Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electronic Health Records | 60 | 2024 | 4881 | 5.010 |
Why?
|
Models, Statistical | 37 | 2022 | 5098 | 3.370 |
Why?
|
Algorithms | 58 | 2025 | 14098 | 3.140 |
Why?
|
Biometry | 18 | 2018 | 571 | 2.910 |
Why?
|
Natural Language Processing | 26 | 2022 | 1202 | 2.370 |
Why?
|
Proportional Hazards Models | 31 | 2022 | 12536 | 2.150 |
Why?
|
Data Interpretation, Statistical | 19 | 2019 | 2698 | 1.840 |
Why?
|
Computer Simulation | 42 | 2023 | 6260 | 1.730 |
Why?
|
Phenotype | 30 | 2023 | 16718 | 1.700 |
Why?
|
Aneurysm, Ruptured | 14 | 2021 | 455 | 1.570 |
Why?
|
Intracranial Aneurysm | 18 | 2024 | 1271 | 1.490 |
Why?
|
ROC Curve | 26 | 2024 | 3618 | 1.370 |
Why?
|
Arthritis, Rheumatoid | 20 | 2023 | 3778 | 1.300 |
Why?
|
International Classification of Diseases | 9 | 2020 | 935 | 1.280 |
Why?
|
Survival Analysis | 18 | 2023 | 10092 | 1.090 |
Why?
|
Risk Assessment | 26 | 2024 | 24299 | 1.080 |
Why?
|
Case-Control Studies | 29 | 2022 | 22254 | 1.000 |
Why?
|
Likelihood Functions | 8 | 2019 | 996 | 0.990 |
Why?
|
Genetic Association Studies | 8 | 2020 | 2744 | 0.990 |
Why?
|
Peptides, Cyclic | 3 | 2017 | 390 | 0.900 |
Why?
|
Information Storage and Retrieval | 4 | 2019 | 833 | 0.890 |
Why?
|
Regression Analysis | 8 | 2017 | 6331 | 0.880 |
Why?
|
Research Design | 8 | 2024 | 6210 | 0.840 |
Why?
|
Sample Size | 10 | 2020 | 845 | 0.790 |
Why?
|
Sigmoid Neoplasms | 1 | 2022 | 55 | 0.790 |
Why?
|
Semantics | 3 | 2025 | 609 | 0.770 |
Why?
|
Autoantibodies | 7 | 2018 | 2114 | 0.760 |
Why?
|
Probability | 7 | 2022 | 2476 | 0.760 |
Why?
|
Data Mining | 5 | 2021 | 561 | 0.720 |
Why?
|
Inflammatory Bowel Diseases | 14 | 2022 | 2441 | 0.700 |
Why?
|
Humans | 233 | 2025 | 767040 | 0.690 |
Why?
|
Medical Record Linkage | 1 | 2021 | 286 | 0.690 |
Why?
|
Prognosis | 27 | 2022 | 29963 | 0.650 |
Why?
|
Validation Studies as Topic | 1 | 2019 | 162 | 0.620 |
Why?
|
Polymorphism, Single Nucleotide | 15 | 2019 | 16036 | 0.610 |
Why?
|
Lipoproteins, LDL | 2 | 2019 | 640 | 0.590 |
Why?
|
Genetic Markers | 3 | 2016 | 2602 | 0.580 |
Why?
|
Lipoproteins, HDL | 5 | 2020 | 679 | 0.570 |
Why?
|
Comparative Effectiveness Research | 1 | 2022 | 713 | 0.560 |
Why?
|
Receptors, Interleukin-6 | 1 | 2018 | 224 | 0.550 |
Why?
|
Meta-Analysis as Topic | 3 | 2010 | 1364 | 0.550 |
Why?
|
Cluster Analysis | 7 | 2023 | 2721 | 0.500 |
Why?
|
Cohort Studies | 41 | 2025 | 41718 | 0.490 |
Why?
|
Colitis, Ulcerative | 9 | 2020 | 1924 | 0.480 |
Why?
|
Aortic Aneurysm | 2 | 2024 | 649 | 0.480 |
Why?
|
Diagnostic Tests, Routine | 3 | 2021 | 788 | 0.480 |
Why?
|
Suicide, Attempted | 6 | 2023 | 1413 | 0.450 |
Why?
|
Area Under Curve | 7 | 2021 | 1639 | 0.450 |
Why?
|
Genome-Wide Association Study | 12 | 2020 | 12790 | 0.440 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2019 | 1023 | 0.440 |
Why?
|
Apolipoprotein C-III | 3 | 2020 | 209 | 0.410 |
Why?
|
Data Collection | 2 | 2023 | 3321 | 0.410 |
Why?
|
Crohn Disease | 8 | 2019 | 2295 | 0.400 |
Why?
|
Models, Genetic | 6 | 2017 | 3445 | 0.380 |
Why?
|
Risk Factors | 42 | 2024 | 74886 | 0.370 |
Why?
|
Lung Neoplasms | 5 | 2023 | 13491 | 0.360 |
Why?
|
Sensitivity and Specificity | 20 | 2020 | 14672 | 0.360 |
Why?
|
Anterior Cerebral Artery | 2 | 2021 | 50 | 0.360 |
Why?
|
Calibration | 2 | 2023 | 817 | 0.360 |
Why?
|
Propensity Score | 5 | 2022 | 1971 | 0.350 |
Why?
|
Epitopes | 1 | 2017 | 2526 | 0.350 |
Why?
|
Laparoscopy | 1 | 2022 | 2037 | 0.350 |
Why?
|
Logistic Models | 16 | 2022 | 13284 | 0.340 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2014 | 700 | 0.340 |
Why?
|
Basilar Artery | 2 | 2021 | 207 | 0.340 |
Why?
|
Female | 112 | 2025 | 396660 | 0.330 |
Why?
|
Biostatistics | 7 | 2013 | 162 | 0.330 |
Why?
|
Middle Aged | 85 | 2024 | 223233 | 0.330 |
Why?
|
Angiography | 5 | 2014 | 1597 | 0.320 |
Why?
|
Male | 100 | 2024 | 364203 | 0.300 |
Why?
|
Multiple Sclerosis | 5 | 2021 | 3229 | 0.300 |
Why?
|
Reproducibility of Results | 18 | 2023 | 20169 | 0.300 |
Why?
|
Aged | 63 | 2024 | 171319 | 0.290 |
Why?
|
Statistics, Nonparametric | 9 | 2019 | 2850 | 0.290 |
Why?
|
Risk | 11 | 2020 | 9606 | 0.290 |
Why?
|
Lipolysis | 1 | 2009 | 211 | 0.290 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3253 | 0.290 |
Why?
|
Life Tables | 1 | 2007 | 367 | 0.290 |
Why?
|
Suicidal Ideation | 4 | 2019 | 1467 | 0.290 |
Why?
|
Unified Medical Language System | 2 | 2019 | 88 | 0.290 |
Why?
|
Forecasting | 3 | 2021 | 2936 | 0.280 |
Why?
|
Models, Theoretical | 3 | 2016 | 3561 | 0.280 |
Why?
|
Smoking | 4 | 2019 | 9081 | 0.280 |
Why?
|
Epidemiologic Studies | 2 | 2021 | 677 | 0.270 |
Why?
|
Linear Models | 7 | 2018 | 5875 | 0.270 |
Why?
|
Coronary Disease | 7 | 2020 | 5914 | 0.270 |
Why?
|
Circle of Willis | 3 | 2021 | 77 | 0.260 |
Why?
|
Multivariate Analysis | 12 | 2020 | 12069 | 0.260 |
Why?
|
Obstetric Labor Complications | 2 | 2019 | 240 | 0.260 |
Why?
|
Cardiovascular Diseases | 14 | 2018 | 15645 | 0.250 |
Why?
|
Epidemiologic Research Design | 1 | 2009 | 368 | 0.250 |
Why?
|
Hospitalization | 12 | 2022 | 10815 | 0.250 |
Why?
|
Receptors, Nicotinic | 1 | 2009 | 494 | 0.250 |
Why?
|
Kaplan-Meier Estimate | 5 | 2014 | 6513 | 0.250 |
Why?
|
Predictive Value of Tests | 15 | 2017 | 15424 | 0.250 |
Why?
|
Pulmonary Embolism | 7 | 2016 | 2598 | 0.250 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2014 | 2204 | 0.250 |
Why?
|
Costs and Cost Analysis | 1 | 2011 | 1666 | 0.240 |
Why?
|
Psychopathology | 3 | 2018 | 434 | 0.240 |
Why?
|
Coronary Artery Disease | 5 | 2019 | 6573 | 0.240 |
Why?
|
Breast Neoplasms | 9 | 2016 | 21178 | 0.240 |
Why?
|
Mental Disorders | 3 | 2020 | 6873 | 0.240 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3667 | 0.230 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1263 | 0.230 |
Why?
|
Discriminant Analysis | 1 | 2004 | 222 | 0.230 |
Why?
|
Survival | 2 | 2017 | 160 | 0.220 |
Why?
|
Clinical Trials as Topic | 5 | 2021 | 8048 | 0.220 |
Why?
|
Medicare | 2 | 2021 | 6813 | 0.220 |
Why?
|
Adult | 65 | 2024 | 223317 | 0.220 |
Why?
|
Genomics | 4 | 2018 | 5924 | 0.220 |
Why?
|
Registries | 7 | 2021 | 8351 | 0.210 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1655 | 0.210 |
Why?
|
Biological Products | 2 | 2023 | 948 | 0.210 |
Why?
|
Databases, Factual | 6 | 2022 | 8068 | 0.210 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 6 | 2014 | 1233 | 0.210 |
Why?
|
Genetic Predisposition to Disease | 11 | 2023 | 18063 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2020 | 10393 | 0.200 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5886 | 0.200 |
Why?
|
Adipocytes | 1 | 2009 | 1197 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 11 | 2016 | 20741 | 0.190 |
Why?
|
Pandemics | 4 | 2022 | 8736 | 0.190 |
Why?
|
Cholesterol, HDL | 3 | 2018 | 1816 | 0.190 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2009 | 1244 | 0.180 |
Why?
|
Dental Implants | 2 | 2006 | 790 | 0.180 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2023 | 1250 | 0.180 |
Why?
|
Biological Therapy | 1 | 2022 | 140 | 0.180 |
Why?
|
Apolipoprotein A-I | 2 | 2020 | 305 | 0.180 |
Why?
|
Bayes Theorem | 3 | 2019 | 2353 | 0.180 |
Why?
|
Genotype | 9 | 2023 | 13035 | 0.180 |
Why?
|
Least-Squares Analysis | 1 | 2021 | 369 | 0.170 |
Why?
|
Pregnancy Complications | 3 | 2019 | 2971 | 0.170 |
Why?
|
Markov Chains | 2 | 2022 | 976 | 0.170 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 271 | 0.170 |
Why?
|
Iopamidol | 3 | 2009 | 188 | 0.170 |
Why?
|
Time Factors | 14 | 2019 | 40154 | 0.170 |
Why?
|
Classification | 2 | 2017 | 128 | 0.170 |
Why?
|
Chondrocalcinosis | 1 | 2021 | 84 | 0.170 |
Why?
|
Disease Progression | 8 | 2021 | 13646 | 0.160 |
Why?
|
AIDS Vaccines | 1 | 2006 | 900 | 0.160 |
Why?
|
Spondylarthritis | 1 | 2020 | 62 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2022 | 4349 | 0.160 |
Why?
|
Apolipoproteins E | 3 | 2020 | 1459 | 0.160 |
Why?
|
Military Personnel | 3 | 2017 | 1261 | 0.160 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2002 | 566 | 0.160 |
Why?
|
Artificial Intelligence | 1 | 2013 | 2666 | 0.160 |
Why?
|
Stochastic Processes | 1 | 2020 | 359 | 0.160 |
Why?
|
Colectomy | 2 | 2022 | 696 | 0.150 |
Why?
|
Prevalence | 9 | 2021 | 15851 | 0.150 |
Why?
|
Spondylitis, Ankylosing | 1 | 2020 | 158 | 0.150 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 857 | 0.150 |
Why?
|
Gastrointestinal Agents | 3 | 2022 | 511 | 0.150 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4567 | 0.150 |
Why?
|
Software | 5 | 2017 | 4472 | 0.150 |
Why?
|
Treatment Outcome | 13 | 2023 | 65295 | 0.150 |
Why?
|
C-Reactive Protein | 4 | 2014 | 3851 | 0.150 |
Why?
|
Nonlinear Dynamics | 2 | 2018 | 490 | 0.150 |
Why?
|
Mortality | 1 | 2009 | 2909 | 0.150 |
Why?
|
Retrospective Studies | 30 | 2024 | 81659 | 0.150 |
Why?
|
Current Procedural Terminology | 1 | 2018 | 101 | 0.150 |
Why?
|
Peer Review, Research | 1 | 2021 | 343 | 0.150 |
Why?
|
Apolipoproteins | 1 | 2019 | 328 | 0.140 |
Why?
|
Receptors, Formyl Peptide | 1 | 2018 | 146 | 0.140 |
Why?
|
Sampling Studies | 2 | 2015 | 614 | 0.140 |
Why?
|
Automation | 1 | 2019 | 587 | 0.140 |
Why?
|
Veterans | 2 | 2022 | 2666 | 0.140 |
Why?
|
Heroin Dependence | 1 | 2017 | 173 | 0.140 |
Why?
|
Contrast Media | 8 | 2012 | 5329 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2018 | 382 | 0.130 |
Why?
|
Patient Selection | 2 | 2021 | 4256 | 0.130 |
Why?
|
Causality | 3 | 2020 | 1253 | 0.130 |
Why?
|
Vitamin D | 3 | 2015 | 3312 | 0.130 |
Why?
|
Hypertension, Pulmonary | 2 | 2017 | 1604 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 551 | 0.130 |
Why?
|
GRB10 Adaptor Protein | 1 | 2015 | 23 | 0.130 |
Why?
|
Dementia | 3 | 2020 | 2741 | 0.130 |
Why?
|
United States | 18 | 2022 | 72971 | 0.130 |
Why?
|
Apolipoproteins C | 1 | 2015 | 59 | 0.130 |
Why?
|
HIV Infections | 6 | 2017 | 17542 | 0.130 |
Why?
|
Comorbidity | 6 | 2022 | 10582 | 0.120 |
Why?
|
Colorectal Neoplasms | 4 | 2017 | 6966 | 0.120 |
Why?
|
Young Adult | 19 | 2023 | 59980 | 0.120 |
Why?
|
Therapeutics | 1 | 2015 | 113 | 0.120 |
Why?
|
Aneurysm | 1 | 2018 | 343 | 0.120 |
Why?
|
Aged, 80 and over | 16 | 2024 | 59548 | 0.120 |
Why?
|
Magnesium | 1 | 2018 | 815 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 892 | 0.120 |
Why?
|
Confidentiality | 1 | 2019 | 607 | 0.120 |
Why?
|
Lipopolysaccharides | 1 | 2002 | 2217 | 0.120 |
Why?
|
Models, Biological | 6 | 2018 | 9464 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 3 | 2022 | 2586 | 0.110 |
Why?
|
Suicide | 2 | 2015 | 1606 | 0.110 |
Why?
|
Prospective Studies | 11 | 2022 | 54886 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 940 | 0.110 |
Why?
|
Vitamin D Deficiency | 2 | 2013 | 1389 | 0.110 |
Why?
|
Textile Industry | 1 | 2013 | 74 | 0.110 |
Why?
|
Publishing | 1 | 2021 | 837 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2019 | 12250 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
Genetic Research | 1 | 2014 | 173 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1379 | 0.110 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2023 | 1456 | 0.110 |
Why?
|
Heart Failure | 4 | 2022 | 11877 | 0.110 |
Why?
|
Medical Audit | 1 | 2014 | 454 | 0.100 |
Why?
|
Blood Sedimentation | 1 | 2014 | 235 | 0.100 |
Why?
|
Hypoglycemic Agents | 3 | 2017 | 3108 | 0.100 |
Why?
|
Electrocardiography | 4 | 2009 | 6409 | 0.100 |
Why?
|
Haplotypes | 1 | 2018 | 2722 | 0.100 |
Why?
|
Anthropometry | 1 | 2017 | 1345 | 0.100 |
Why?
|
Drug Therapy | 1 | 2015 | 504 | 0.100 |
Why?
|
Survival Rate | 5 | 2014 | 12823 | 0.100 |
Why?
|
Arousal | 1 | 2018 | 1174 | 0.100 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 179 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 2 | 2010 | 1429 | 0.100 |
Why?
|
Adolescent | 15 | 2023 | 89046 | 0.100 |
Why?
|
Lung Diseases | 2 | 2013 | 1942 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 877 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1178 | 0.090 |
Why?
|
Antibodies, Antinuclear | 1 | 2013 | 340 | 0.090 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2745 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 5 | 2021 | 4052 | 0.090 |
Why?
|
Genetic Variation | 3 | 2017 | 6611 | 0.090 |
Why?
|
Endotoxins | 1 | 2013 | 519 | 0.090 |
Why?
|
Biomedical Research | 2 | 2021 | 3464 | 0.090 |
Why?
|
Air Pollutants, Occupational | 1 | 2013 | 406 | 0.090 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 212 | 0.090 |
Why?
|
Sjogren's Syndrome | 1 | 2013 | 240 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1660 | 0.090 |
Why?
|
Pregnant Women | 1 | 2015 | 576 | 0.090 |
Why?
|
Statistical Distributions | 1 | 2010 | 62 | 0.090 |
Why?
|
Sequence Analysis | 1 | 2011 | 240 | 0.090 |
Why?
|
Anticoagulants | 2 | 2018 | 4854 | 0.090 |
Why?
|
Parturition | 1 | 2014 | 454 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1811 | 0.090 |
Why?
|
Hyperlipidemias | 1 | 2015 | 771 | 0.090 |
Why?
|
Pregnancy Outcome | 2 | 2019 | 2972 | 0.090 |
Why?
|
Thiazolidinediones | 2 | 2010 | 460 | 0.090 |
Why?
|
Deoxyguanosine | 1 | 2010 | 96 | 0.090 |
Why?
|
Longitudinal Studies | 5 | 2021 | 14766 | 0.090 |
Why?
|
Epigenomics | 1 | 2016 | 959 | 0.090 |
Why?
|
Reference Values | 2 | 2007 | 4918 | 0.090 |
Why?
|
Depressive Disorder | 2 | 2013 | 3721 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1493 | 0.080 |
Why?
|
Endovascular Procedures | 1 | 2023 | 2215 | 0.080 |
Why?
|
Boston | 6 | 2021 | 9360 | 0.080 |
Why?
|
Fractures, Bone | 1 | 2021 | 2062 | 0.080 |
Why?
|
Self-Injurious Behavior | 1 | 2015 | 571 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 2 | 2021 | 331 | 0.080 |
Why?
|
Bipolar Disorder | 2 | 2018 | 5130 | 0.080 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2009 | 87 | 0.080 |
Why?
|
Poisson Distribution | 1 | 2010 | 507 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2021 | 15925 | 0.080 |
Why?
|
Cinnamates | 1 | 2009 | 59 | 0.080 |
Why?
|
Lipoproteins | 1 | 2013 | 871 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1883 | 0.080 |
Why?
|
Radioligand Assay | 1 | 2009 | 365 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1900 | 0.080 |
Why?
|
Endpoint Determination | 1 | 2011 | 592 | 0.080 |
Why?
|
Coronary Angiography | 3 | 2009 | 4525 | 0.070 |
Why?
|
Birth Weight | 1 | 2016 | 2122 | 0.070 |
Why?
|
Autistic Disorder | 1 | 2017 | 1239 | 0.070 |
Why?
|
Iodine | 1 | 2010 | 285 | 0.070 |
Why?
|
Hypothyroidism | 1 | 2013 | 667 | 0.070 |
Why?
|
Heart Ventricles | 2 | 2012 | 3837 | 0.070 |
Why?
|
Thrombosis | 1 | 2022 | 2954 | 0.070 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2008 | 146 | 0.070 |
Why?
|
Drug Combinations | 1 | 2014 | 2086 | 0.070 |
Why?
|
Carrier Proteins | 2 | 2018 | 4925 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3567 | 0.070 |
Why?
|
Patient Positioning | 1 | 2010 | 332 | 0.070 |
Why?
|
Iodine Compounds | 1 | 2007 | 28 | 0.070 |
Why?
|
Arthritis, Psoriatic | 1 | 2010 | 219 | 0.070 |
Why?
|
Thromboembolism | 1 | 2014 | 1003 | 0.070 |
Why?
|
Delivery, Obstetric | 1 | 2014 | 949 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 488 | 0.070 |
Why?
|
Cognition | 3 | 2020 | 7059 | 0.070 |
Why?
|
Neoplasms | 5 | 2018 | 22350 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3135 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2010 | 538 | 0.070 |
Why?
|
HIV-1 | 2 | 2017 | 6951 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 806 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4780 | 0.070 |
Why?
|
Erythropoietin | 1 | 2011 | 718 | 0.070 |
Why?
|
Washington | 1 | 2007 | 315 | 0.070 |
Why?
|
Follow-Up Studies | 9 | 2020 | 39317 | 0.070 |
Why?
|
Cystic Fibrosis | 2 | 2007 | 1292 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2160 | 0.070 |
Why?
|
Denmark | 2 | 2019 | 776 | 0.070 |
Why?
|
Colonoscopy | 1 | 2014 | 1409 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 744 | 0.060 |
Why?
|
Odds Ratio | 4 | 2019 | 9660 | 0.060 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 369 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2017 | 3468 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2013 | 872 | 0.060 |
Why?
|
Veins | 1 | 2010 | 769 | 0.060 |
Why?
|
Peptides | 1 | 2018 | 4348 | 0.060 |
Why?
|
Radiographic Image Enhancement | 1 | 2010 | 877 | 0.060 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2016 | 1417 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2085 | 0.060 |
Why?
|
Cesarean Section | 1 | 2014 | 1419 | 0.060 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2016 | 1389 | 0.060 |
Why?
|
Dental Implantation, Endosseous | 2 | 2006 | 519 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3931 | 0.060 |
Why?
|
Plant Extracts | 1 | 2009 | 496 | 0.060 |
Why?
|
Incidence | 7 | 2022 | 21526 | 0.060 |
Why?
|
Clostridium Infections | 1 | 2012 | 562 | 0.060 |
Why?
|
Calcium | 1 | 2018 | 5792 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 6310 | 0.060 |
Why?
|
Proteomics | 1 | 2018 | 3913 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2519 | 0.060 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 6106 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2920 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3854 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 11923 | 0.060 |
Why?
|
Artifacts | 2 | 2010 | 1904 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3249 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2004 | 109 | 0.060 |
Why?
|
Molecular Structure | 1 | 2009 | 1882 | 0.060 |
Why?
|
Dental Research | 1 | 2005 | 61 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4045 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2011 | 1758 | 0.060 |
Why?
|
Dental Restoration Failure | 1 | 2005 | 155 | 0.060 |
Why?
|
Pulmonary Artery | 2 | 2010 | 1944 | 0.060 |
Why?
|
Reference Standards | 1 | 2007 | 1011 | 0.060 |
Why?
|
Glioblastoma | 2 | 2016 | 3461 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9410 | 0.060 |
Why?
|
Age Factors | 3 | 2021 | 18401 | 0.050 |
Why?
|
Respiration | 1 | 2010 | 1655 | 0.050 |
Why?
|
Recurrence | 3 | 2021 | 8504 | 0.050 |
Why?
|
Population Surveillance | 1 | 2014 | 2594 | 0.050 |
Why?
|
Psychotic Disorders | 1 | 2019 | 3275 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2513 | 0.050 |
Why?
|
Child | 10 | 2022 | 80771 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7871 | 0.050 |
Why?
|
Occupational Exposure | 1 | 2013 | 1807 | 0.050 |
Why?
|
Endoleak | 1 | 2023 | 111 | 0.050 |
Why?
|
Pattern Recognition, Automated | 1 | 2009 | 987 | 0.050 |
Why?
|
Kidney Failure, Chronic | 2 | 2016 | 2495 | 0.050 |
Why?
|
Orphan Nuclear Receptors | 1 | 2003 | 63 | 0.050 |
Why?
|
Sequence Homology | 1 | 2003 | 197 | 0.050 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2002 | 28 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3322 | 0.050 |
Why?
|
Angiopoietins | 1 | 2003 | 86 | 0.050 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2008 | 645 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3700 | 0.050 |
Why?
|
CA-125 Antigen | 1 | 2004 | 281 | 0.050 |
Why?
|
RNA, Viral | 1 | 2010 | 2867 | 0.050 |
Why?
|
Lower Extremity | 1 | 2010 | 1217 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2007 | 1443 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2255 | 0.050 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 26325 | 0.050 |
Why?
|
Medical Records | 1 | 2007 | 1409 | 0.050 |
Why?
|
Renal Dialysis | 1 | 2011 | 1790 | 0.050 |
Why?
|
Pregnancy | 6 | 2019 | 30238 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2010 | 1506 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2003 | 5796 | 0.050 |
Why?
|
Massachusetts | 4 | 2018 | 8890 | 0.050 |
Why?
|
Obesity | 2 | 2023 | 13085 | 0.050 |
Why?
|
Prostatic Neoplasms | 4 | 2011 | 11097 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2010 | 1787 | 0.040 |
Why?
|
Body Height | 1 | 2007 | 1565 | 0.040 |
Why?
|
Creatinine | 2 | 2019 | 1916 | 0.040 |
Why?
|
Liver Cirrhosis, Biliary | 2 | 2012 | 108 | 0.040 |
Why?
|
Privacy | 1 | 2022 | 233 | 0.040 |
Why?
|
British Columbia | 1 | 2020 | 239 | 0.040 |
Why?
|
Hemophilia A | 1 | 2003 | 359 | 0.040 |
Why?
|
Research | 2 | 2023 | 1977 | 0.040 |
Why?
|
Neuropsychological Tests | 3 | 2020 | 7121 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2011 | 2463 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2004 | 1830 | 0.040 |
Why?
|
Psychiatry | 1 | 2011 | 1715 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 694 | 0.040 |
Why?
|
Child, Preschool | 5 | 2021 | 42606 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1442 | 0.040 |
Why?
|
Alleles | 2 | 2023 | 6893 | 0.040 |
Why?
|
Colestipol | 1 | 2018 | 10 | 0.040 |
Why?
|
Epilepsy | 1 | 2014 | 3317 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
Vital Signs | 1 | 2019 | 144 | 0.040 |
Why?
|
Blood Vessel Prosthesis | 1 | 2023 | 956 | 0.040 |
Why?
|
Observer Variation | 3 | 2010 | 2616 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2009 | 3114 | 0.040 |
Why?
|
Fibric Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2016 | 4629 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2018 | 7848 | 0.040 |
Why?
|
Triglycerides | 2 | 2020 | 2444 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 3804 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5537 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 365 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1334 | 0.040 |
Why?
|
Public Health | 1 | 2011 | 2681 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2008 | 2144 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1244 | 0.040 |
Why?
|
Stroke Volume | 2 | 2022 | 5618 | 0.030 |
Why?
|
Protein Stability | 1 | 2018 | 578 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2012 | 6215 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2017 | 266 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2010 | 3968 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 601 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2021 | 26396 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2014 | 4813 | 0.030 |
Why?
|
Hemostasis | 1 | 2018 | 467 | 0.030 |
Why?
|
Independent Living | 1 | 2020 | 584 | 0.030 |
Why?
|
Depression | 1 | 2015 | 8234 | 0.030 |
Why?
|
Monte Carlo Method | 2 | 2012 | 1250 | 0.030 |
Why?
|
Waist Circumference | 1 | 2019 | 935 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2021 | 5311 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2264 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1733 | 0.030 |
Why?
|
Ligands | 1 | 2002 | 3273 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2016 | 350 | 0.030 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2016 | 276 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2018 | 561 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2016 | 386 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2016 | 296 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4026 | 0.030 |
Why?
|
Genetic Loci | 2 | 2016 | 2629 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2016 | 15824 | 0.030 |
Why?
|
Cotton Fiber | 1 | 2013 | 25 | 0.030 |
Why?
|
Rectal Fistula | 1 | 2014 | 76 | 0.030 |
Why?
|
Americas | 1 | 2014 | 110 | 0.030 |
Why?
|
Gene Frequency | 2 | 2011 | 3621 | 0.030 |
Why?
|
Botswana | 1 | 2017 | 1056 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2021 | 8940 | 0.030 |
Why?
|
Mice | 3 | 2009 | 81912 | 0.030 |
Why?
|
Cholesterol | 1 | 2003 | 2905 | 0.030 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 166 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8628 | 0.030 |
Why?
|
Genetic Linkage | 1 | 1999 | 2342 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2009 | 14476 | 0.030 |
Why?
|
New Zealand | 1 | 2014 | 360 | 0.030 |
Why?
|
Piperidines | 1 | 2022 | 1667 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 18989 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 862 | 0.030 |
Why?
|
Thyroiditis | 1 | 2013 | 86 | 0.030 |
Why?
|
Penicillamine | 1 | 2012 | 60 | 0.020 |
Why?
|
Asia | 1 | 2014 | 629 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2078 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2018 | 1196 | 0.020 |
Why?
|
Base Sequence | 1 | 2003 | 12414 | 0.020 |
Why?
|
Transglutaminases | 1 | 2013 | 200 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9532 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 404 | 0.020 |
Why?
|
Iodide Peroxidase | 1 | 2013 | 295 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 383 | 0.020 |
Why?
|
Inflammation | 2 | 2022 | 10869 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5389 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 520 | 0.020 |
Why?
|
Dust | 1 | 2013 | 488 | 0.020 |
Why?
|
Nigeria | 1 | 2014 | 781 | 0.020 |
Why?
|
Antioxidants | 1 | 2018 | 1671 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2381 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1895 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 17608 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 570 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1243 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1641 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2870 | 0.020 |
Why?
|
Sex Factors | 2 | 2015 | 10622 | 0.020 |
Why?
|
Postoperative Care | 1 | 2016 | 1480 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2840 | 0.020 |
Why?
|
Pyrimidines | 1 | 2022 | 3044 | 0.020 |
Why?
|
Adiposity | 1 | 2019 | 1894 | 0.020 |
Why?
|
Hospital Information Systems | 1 | 2012 | 395 | 0.020 |
Why?
|
Iohexol | 1 | 2010 | 205 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2010 | 11513 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2900 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 935 | 0.020 |
Why?
|
Radiation Dosage | 2 | 2008 | 1965 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2011 | 353 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 584 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36485 | 0.020 |
Why?
|
Puerto Rico | 1 | 2010 | 380 | 0.020 |
Why?
|
Hepatitis C | 1 | 2019 | 1594 | 0.020 |
Why?
|
Needs Assessment | 1 | 2015 | 1141 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 946 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4210 | 0.020 |
Why?
|
Serum Albumin | 1 | 2012 | 676 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2008 | 120 | 0.020 |
Why?
|
Animals | 3 | 2009 | 168965 | 0.020 |
Why?
|
Aftercare | 1 | 2015 | 915 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2276 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2392 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3431 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3272 | 0.020 |
Why?
|
New England | 1 | 2011 | 1058 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3883 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3618 | 0.020 |
Why?
|
Viral Load | 1 | 2017 | 3385 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2018 | 6023 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3530 | 0.020 |
Why?
|
China | 1 | 2013 | 2394 | 0.020 |
Why?
|
Taiwan | 1 | 2008 | 521 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 888 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 13048 | 0.020 |
Why?
|
Liver | 1 | 2003 | 7578 | 0.020 |
Why?
|
Europe | 1 | 2014 | 3432 | 0.020 |
Why?
|
Resilience, Psychological | 1 | 2015 | 807 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2019 | 3070 | 0.020 |
Why?
|
Vascular Patency | 1 | 2010 | 915 | 0.020 |
Why?
|
Family | 1 | 2017 | 3210 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1804 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9327 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1996 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10748 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2007 | 876 | 0.020 |
Why?
|
Hemoglobins | 1 | 2012 | 1531 | 0.020 |
Why?
|
Genetic Testing | 1 | 1999 | 3591 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12451 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9612 | 0.020 |
Why?
|
Tyrosine | 1 | 2009 | 1425 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2014 | 1592 | 0.020 |
Why?
|
DNA | 1 | 2017 | 7210 | 0.010 |
Why?
|
Dental Prosthesis Design | 1 | 2005 | 255 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11217 | 0.010 |
Why?
|
Benchmarking | 1 | 2008 | 1056 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2010 | 1523 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3467 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2428 | 0.010 |
Why?
|
Patient Readmission | 1 | 2014 | 3283 | 0.010 |
Why?
|
Exercise | 1 | 2017 | 5954 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2011 | 2780 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2008 | 1388 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3726 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2010 | 3139 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8310 | 0.010 |
Why?
|
Lod Score | 1 | 1999 | 600 | 0.010 |
Why?
|
Acute Disease | 1 | 2008 | 7236 | 0.010 |
Why?
|
Heart Rate | 1 | 2008 | 4209 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6975 | 0.010 |
Why?
|
Pilot Projects | 1 | 2008 | 8732 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2008 | 2930 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36582 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9245 | 0.010 |
Why?
|
Gene Expression | 1 | 2006 | 7587 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 17097 | 0.010 |
Why?
|
Blood Pressure | 1 | 2008 | 8531 | 0.010 |
Why?
|
Mass Screening | 1 | 2007 | 5456 | 0.010 |
Why?
|
Genome | 1 | 1999 | 1752 | 0.010 |
Why?
|
Signal Transduction | 1 | 2009 | 23621 | 0.000 |
Why?
|